Abbott Laboratories v. Young’s Empirical Analysis
920 F.2d 984 · 1990
Citation profile
28 federal appellate · 24 district · 5 state decisions
How this case has been cited
Cited by 74 later decisions — most recently January 2023 · most notably State v. Thomas (2001), National Mining Ass'n v. U.S. Army Corps of Engineers (1998)
28 federal appellate · 24 district · 5 state decisions
Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.
Relationships
Applies 21 U.S.C. § 355 (Federal Food, Drug, and Cosmetic Act)
Relies on Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc. · Motor Vehicle Manufacturers Association of United States Inc v. State Farm Mutual Automobile Insurance Company Consumer Alert · Immigration & Naturalization Service v. Cardoza-Fonseca · Consumer Product Safety Commission v. GTE Sylvania, Inc. · Mart Corporation v. Cartier Inc 47th Street Photo Inc
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 74 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“[I]t is not impermissible under Chevron for an agency to interpret [the same] imprecise term differently in two separate sections of a statute which have different purposes.”
4 later decisions quote this exact passage · from the majority“[t]he `reasonableness' of an agency's construction depends on the construction's `fit' with the statutory language as well as its conformity to statutory purposes.”
4 later decisions quote this exact passage · from the majority“two conflicting policy objectives: to induce name-brand pharmaceutical firms to make the investments necessary to research and develop new drug products, while simultaneously enabling competitors to bring cheaper, generic copies of those drugs to market.”
3 later decisions quote this exact passage · from the dissent
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.